INS and diabetes mellitus: Also, systemic exposure to gabapentin after administration of a single dose at 50 mg/kg i.p. at 19-days after STZ-diabetes induction in rats, did not differ significantly from that for similar STZ-diabetic rats rendered euglycemic by insulin treatment (Benzi et al., 2018).